Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2)

被引:19
|
作者
Ninomiya, Mizuki
Ito, Kousei
Hiramatsu, Remi
Horie, Toshiharu
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Biopharmaceut, Chuo Ku, Chiba 2608675, Japan
[2] Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan
关键词
D O I
10.1124/dmd.106.010991
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the intrinsic transport activity of mouse and monkey Mrp2 and compared it with that of rat and dog Mrp2 reported previously. Mrp2 cDNAs were isolated from BALB/c and Macaca fascicularis liver, respectively, and vesicle transport studies were performed using recombinant Mrp2s expressed in insect Sf9 cells. ATP-dependent transport of [H-3] leukotriene C-4 (LTC4), [H-3]17 beta-estradiol 17-(beta-D-glucuronide) (E(2)17 beta G), [H-3]bromosulfophthalein (BSP), and [H-3]cholecystokinin octapeptide (CCK-8) were readily detected for all Mrp2s. A species difference in the intrinsic transport activity was apparent for LTC4 (monkey > mouse, dog > rat) and BSP ( rat, dog, monkey > mouse). In addition to the difference in the transport activity, complex kinetic profiles were also evident in CCK-8, where a cooperative transport site was observed. Moreover, the transport of [H-3]E(2)17 beta G by mouse and monkey Mrp2 was quite different from that of rat and dog Mrp2 in that 1) there was practically only nonsaturable uptake for [H-3]E(2)17 beta G and 2) 4-methylumbelliferon glucuronide (Mrp2 modulator) showed a concentration-dependent stimulatory effect on the transport of [H-3]E(2)17 beta G in mouse and monkey Mrp2, whereas rat and dog transport activity was inhibited by the modulator. In conclusion, although the substrate specificity is similar, the intrinsic transport activity differs from one species to another. This is due not only to the difference in the K-m and V-max values, but also the qualitatively different mode of substrate and modulator recognition exhibited by different species.
引用
收藏
页码:2056 / 2063
页数:8
相关论文
共 50 条
  • [11] Induction of hepatic and intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone (SL)
    Catania, VA
    Luquita, MG
    Pozzi, EJS
    Pellegrino, JM
    Ochoa, JE
    Mottino, AD
    JOURNAL OF HEPATOLOGY, 2002, 36 : 251 - 251
  • [12] Molecular characterization of a multidrug resistance-associated protein, Mrp2, from the little skate
    Cai, SY
    Soroka, CJ
    Ballatori, N
    Boyer, JL
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 284 (01) : R125 - R130
  • [13] Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human
    Li, Na
    Zhang, Yiqun
    Hua, Fengmei
    Lai, Yurong
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) : 66 - 73
  • [14] EFFECT OF MONOGLYCERIDES ON MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) WITHIN CACO-2 CELLS
    Jia, Xi
    Wasan, Kishor M.
    DRUG METABOLISM REVIEWS, 2008, 40 : 172 - 172
  • [15] Expression of MRP2 (multidrug resistance-associated protein2) regulates the drug resistance of human pancreatic cancer
    Noma, Bunjiro
    Sasaki, Tamito
    Fujimoto, Yoshifumi
    Kuwahara, Kenichi
    Serikawa, Masahiro
    Kobayashi, Kenso
    Ituki, Hiroshi
    Chayama, Kazuaki
    GASTROENTEROLOGY, 2008, 134 (04) : A454 - A454
  • [16] Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone
    Courtois, A
    Payen, L
    Guillouzo, A
    Fardel, O
    FEBS LETTERS, 1999, 459 (03) : 381 - 385
  • [17] Expression of multidrug resistance-associated protein 2 (MRP2) in human intraductal papillary mucinous tumor of pancreas
    Serikawa, M
    Sasaki, T
    Morinaka, K
    Kariya, K
    Yamasaki, S
    Murakami, M
    Kuwada, Y
    Kuwahara, K
    Miyata, H
    Sugiyama, S
    Iiboshi, T
    Chayama, K
    GASTROENTEROLOGY, 2003, 124 (04) : A183 - A183
  • [18] MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) AFFECTS TACROLIMUS DISPOSITION IN A HAPLOTYPE-SPECIFIC MANNER
    Ogasawara, K.
    Chitnis, S. D.
    Gohh, R. Y.
    Christians, U.
    Akhlaghi, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S82 - S82
  • [19] Identification of the apical membrane-targeting signal of the multidrug resistance-associated protein 2 (MRP2/cMOAT)
    Harris, MJ
    Kuwano, M
    Webb, M
    Board, PG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) : 20876 - 20881
  • [20] Transport interaction of the multidrug resistance-associated protein 2 (MRP2) with cholestatic and noncholestatic estrogen glucuronides.
    Gerk, PM
    Li, W
    Vore, M
    HEPATOLOGY, 2002, 36 (04) : 454A - 454A